Asymmetrical Dimethylarginine Is Increased in Plasma and Decreased in Cerebrospinal Fluid of Patients with Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|26|1|58-64

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.26, Iss.1, 2008-07, pp. : 58-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 6, 2008-05 ,pp. : 508-515

Karger

Access to resources Recommend Favorite

The Cerebrospinal Fluid Level of Glial Fibrillary Acidic Protein Is Increased in Cerebrospinal Fluid from Alzheimer’s Disease Patients and Correlates with Severity of Dementia

By  

European Neurology, Vol. 46, Iss. 1, 2001-07 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

Inflammatory Markers in Matched Plasma and Cerebrospinal Fluid from Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 16, Iss. 3, 2003-07 ,pp. : 136-144

Karger

Access to resources Recommend Favorite

Increased Levels of Soluble LR11 in Cerebrospinal Fluid of Patients with Alzheimer Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 30, Iss. 1, 2010-07 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

Effects of Omega-3 Fatty Acids on Inflammatory Markers in Cerebrospinal Fluid and Plasma in Alzheimer’s Disease: The OmegAD Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 5, 2009-05 ,pp. : 481-490

Karger

Access to resources Recommend Favorite